Establishing cut-off points with clinical relevance for bcl-2, cyclin D1, p16, p21, p27, p53, Sox11 and WT1 expression in glioblastoma - a short report
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Link
http://link.springer.com/article/10.1007/s13402-017-0362-4/fulltext.html
Reference38 articles.
1. B. Tran, M.A. Rosenthal, Survival comparison between glioblastoma multiforme and other incurable cancers. J Clin Neurosci 17, 417–421 (2010). https://doi.org/10.1016/j.jocn.2009.09.004
2. M. Touat, A. Idbaih, M. Sanson, K.L. Ligon, Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol 28, 1457–1472 (2017). https://doi.org/10.1093/annonc/mdx106
3. H.J. Anderson, D.S. Galileo, Small-molecule inhibitors of FGFR, integrins and FAK selectively decrease L1CAM-stimulated glioblastoma cell motility and proliferation. Cell Oncol 39, 229–242 (2016). https://doi.org/10.1007/s13402-016-0267-7
4. D. Matias, J. Balca-Silva, L.G. Dubois, B. Pontes, V.P. Ferrer, L. Rosario, A. do Carmo, J. Echevarria-Lima, A.B. Sarmento-Ribeiro, M.C. Lopes, V. Moura-Neto, Dual treatment with shikonin and temozolomide reduces glioblastoma tumor growth, migration and glial-to-mesenchymal transition. Cell Oncol 40, 247–261 (2017). https://doi.org/10.1007/s13402-017-0320-1
5. R. Fisher, L. Pusztai, C. Swanton, Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer 108, 479–485 (2013). https://doi.org/10.1038/bjc.2012.581
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway;Cell Death & Disease;2024-03-01
2. Diagnostic Utility of Immunohistochemical Detection of MEOX2, SOX11, INSM1 and EGFR in Gliomas;Diagnostics;2023-07-31
3. PINK1 Immunoexpression Predicts Survival in Patients Undergoing Hepatic Resection for Colorectal Liver Metastases;International Journal of Molecular Sciences;2023-03-30
4. Prognostic value of Ki-67 index in primary intracranial tumors of infants;Child's Nervous System;2023-01-06
5. The Role of Network Science in Glioblastoma;Cancers;2021-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3